US Dietary Guidelines, Vaccine Confidence Shake-up, and Biopharma Battles Highlight Health News
A summary of current health news includes the anticipated release of U.S. dietary guidelines, potential impacts of vaccine confidence from CDC advisory changes, a new trial by Novo Nordisk for obesity treatment, reinstatement of CDC employees, FDA approval of a new lung cancer drug, and corporate maneuvers in healthcare investments.
The release of the U.S. Dietary Guidelines is anticipated this month, aimed at influencing school lunch programs and nutrition standards. However, school districts are constrained by late timing in adjusting to new guidelines.
In a move that experts warn could undermine vaccine confidence, Health Secretary Robert F. Kennedy Jr. fired the CDC's Advisory Committee for Immunization Practices to reinstate trust in vaccines. Critics believe this could risk Americans' protection against preventable diseases.
Novo Nordisk has initiated a fresh trial for its obesity drug, CagriSema, after prior disappointing results. Concurrently, the CDC rehires 450 employees laid off previously. The FDA also announces the approval of Nuvation Bio's Ibtrozi for a rare lung cancer.
(With inputs from agencies.)
ALSO READ
Novo Nordisk Advances Revolutionary Weight-Loss Drug to Late-Stage Trials
Novo Nordisk's CagriSema: A New Hope in Obesity Treatment Trials
Health Headlines: Novo Nordisk Stake Amid Weight-Loss Market Concerns and Australia's IVF Oversight
Novo Nordisk's Next-Gen Obesity Drug: A New Hope with CagriSema
Novo Nordisk's Next-Gen Obesity Treatment: A New Hope in Weight Loss
Google News